US Stock MarketDetailed Quotes

INAB In8bio

Watchlist

0.271
+0.041+17.77%

Close Oct 18 16:00 ET

0.273
+0.002+0.85%

Post 19:57 ET

19.66MMarket Cap-330P/E (TTM)

In8bio Stock Forum

Stock_Drift

Oct 14 07:09

Pre Market Ticks. 8:07am 10/14

$Destiny Tech100 (DXYZ.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $In8bio (INAB.US)$ $Rani Therapeutics (RANI.US)$ $Jasper Therapeutics (JSPR.US)$ $B Riley Financial Inc 7.5% Sr Nts 31/05/2027 Usd25 (RILYZ.US)$ $B. Riley Financial Inc (RILYP.US)$ $B Riley Financial Inc 6.375% Senior Notes Due 2025 (RILYM.US)$ $B. Riley Financial (RILY.US)$ $Longboard Pharmaceuticals (LBPH.US)$ $Expion360 (XPON.US)$ $Inventiva (IVA.US)$ $Tevogen Bio Holdings (TVGN.US)$

Trytosaveabit

Oct 11 18:51

New Form 13!

$In8bio (INAB.US)$ In8bio | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BIOS CAPITAL MANAGEMENT, LP(23.1%),BIOS ADVISORS GP, LLC(23.1%), etc.
SEC· 18:04

Trytosaveabit

Oct 9 16:26

Update

$In8bio (INAB.US)$ In8bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(9.3%),Orin H(9.3%)
SEC· 3 mins ago

Trytosaveabit

Oct 2 03:17

PP filed 8K last evening

$In8bio (INAB.US)$ On September 30, 2024, In8bio, Inc. announced the entry into a Securities Purchase Agreement with certain investors for a private placement. The agreement involves the sale of approximately 25.76 million shares of common stock, 5.65 million pre-funded warrants, and 31.41 million Series C warrants, generating initial gross proceeds of around $12.4 million. This capital is intended to support the company's operations into 2026. The pre-funded warrants have...

$In8bio (INAB.US)$ Luckily didnt hold this…

Trytosaveabit

Sep 4 15:07

A bit more

$In8bio (INAB.US)$ IN8bio Announces Clinical Pipeline Prioritization To Focus On INB-100 For Acute Myeloid Leukemia And A Workforce Reduction Of ~49%; Suspending Enrollment Of Phase 2 Clinical Trial Of INB-400 In Newly Diagnosed GBM; Will Continue To Monitor Patients For Long-Term Remissions And Overall Survival In Both INB-400 And INB-200 At UAB
Top Priority Clinical Program: Working to drive significant value creation with INB-100 for AML; ongoing trial is actively enrolling additiona...

Trytosaveabit

Sep 4 15:03

Update

$In8bio (INAB.US)$ Reuters· 1 min ago
IN8bio, Inc. - a Workforce Reduction of 49%

Trytosaveabit

Aug 12 07:07

Update

$In8bio (INAB.US)$ Reuters· 1 min ago
IN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology With 100% of Treated Aml Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of Inb-100

Fernando filpo

Jul 25 03:49

$In8bio (INAB.US)$ 🙏🏻 3.25📈📈📈📈📈📈📈📊💹📶💲

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Top Gainers Yesterday

Intraday-1.08%